Back to Obstetrics & Gynecology
Obstetrics & Gynecologyv2016Evidence-Based

sFlt-1/PlGF Ratio (Preeclampsia)

Angiogenic ratio for preeclampsia triage: <38 rules out PE within 1 week; >85/<34w or >110/>=34w rules in.

Clinical Input Parameters

pg/mL
Range: 10 — 100000 pg/mL
pg/mL
Range: 1 — 10000 pg/mL
Range: 20 — 42
Clinical Assessment
Awaiting Parameters
ratio
—ratio
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The sFlt-1/PlGF Ratio (Preeclampsia) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within obstetrics & gynecology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Ratio = sFlt-1 (pg/mL) / PlGF (pg/mL)

Clinical Pearls & Practice Notes

  • PROGNOSIS study cutoffs
  • <38: NPV 99.3% for no preeclampsia within 1 week

Evidence & Literature Citations

  1. Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13-22.

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.